A patient receiving metoclopramide is also taking an antidepressant. What should the nurse monitor for?
Decreased appetite
Increased risk of serotonin syndrome
Elevated blood pressure
Enhanced antidepressant effects
The Correct Answer is B
A. Decreased appetite may occur but is not the most critical concern in this context.
B. The combination of metoclopramide, which can influence serotonin pathways, with certain antidepressants, especially SSRIs, increases the risk of serotonin syndrome, a potentially life-threatening condition.
C. While some antidepressants can influence blood pressure, monitoring for elevated blood pressure is not the primary concern with metoclopramide.
D. There is no evidence to suggest that metoclopramide enhances the effects of antidepressants; the focus should be on potential adverse interactions instead.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is A
Explanation
A. Lorazepam is a benzodiazepine commonly used to manage alcohol withdrawal symptoms, including seizures. It acts quickly to reduce anxiety and seizure activity.
B. Phenytoin is primarily used for seizure control in conditions such as epilepsy but is not the first-line treatment for alcohol withdrawal seizures.
C. Ethosuximide is specifically used for absence seizures and is not effective for alcohol withdrawal.
D. Gabapentin is sometimes used for neuropathic pain but is not indicated for acute alcohol withdrawal or seizure management.
Correct Answer is B
Explanation
A. Hypertension is not a common side effect of antiplatelet therapy; rather, it may be managed or monitored during treatment.
B. Gastrointestinal bleeding is a well-documented side effect of antiplatelet medications like clopidogrel, as they inhibit platelet aggregation and can increase bleeding risk.
C. Hyperglycemia is not typically associated with antiplatelet therapy; it is more commonly related to corticosteroids or certain diabetic medications.
D. Tachycardia is not a common side effect of antiplatelet therapy; cardiovascular effects are usually related to the management of existing conditions.